{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:15:34Z","timestamp":1790777734731,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2008,7,21]],"date-time":"2008-07-21T00:00:00Z","timestamp":1216598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,21]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>The eye represents an ideal and frequent site for the allergic reactions. The term \u2018allergic conjunctivitis\u2019 refers to a collection of disorders that affect the lid, conjunctiva and\/or cornea. Even though the diagnosis is essentially clinical, local tests such as cytology, conjunctival provocation and tear mediator analysis can be performed. The immunoglobulin E (IgE)-mediated mechanism does not explain completely the severity and the clinical course of chronic allergic ocular diseases such as vernal (VKC) and atopic keratoconjunctivitis (AKC), which are probably also related to T cell-mediated responses, massive eosinophil attraction and activation and non-specific hypersensitivity. An altered balance between T helper type 1 (Th1) and Th2 cells and between Th1- and Th2-types of cytokines is thought to be responsible of the development of ocular allergic disorders. New findings suggest that a wide range of cytokines, chemokines, proteases and growth factors are involved by complex interwoven interactions rather than distinct and parallel pathways. In addition, several non-specific enzymatic systems may be activated during acute and chronic allergic inflammation, thus contributing to the complex pathogenesis of the disease. Current drug treatment for ocular allergy targets the key mechanisms involved in the development of clinical disease: mast cells with mast cell stabilizers, histamine with histamine receptor antagonists and inflammation with corticosteroids, severe inflammation with immunomodulators. None of these agents lacks side effects and none abolishes signs and symptoms completely. New therapeutic strategies are still needed to respond to the complex pathogenesis of severe forms of ocular allergy such as VKC and AKC.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2008.03716.x","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T06:41:47Z","timestamp":1223707307000},"page":"17-21","source":"Crossref","is-referenced-by-count":112,"title":["Allergy and the eye"],"prefix":"10.1093","volume":"153","author":[{"given":"A","family":"Leonardi","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Department of Neuroscience, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Motterle","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Neuroscience, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bortolotti","sequence":"additional","affiliation":[{"name":"Ophthalmology Unit, Department of Neuroscience, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,7,21]]},"reference":[{"key":"2022010405125338800_b1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2022010405125338800_b2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","article-title":"Vernal keratoconjunctivitis: pathogenesis and treatment","volume":"21","author":"Leonardi","year":"2002","journal-title":"Prog Ret Eye Res"},{"key":"2022010405125338800_b3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","article-title":"Vernal keratoconjunctivitis revisited. A case series of 195 patients with long-term followup","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"2022010405125338800_b4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2222.2003.01538.x","article-title":"Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms","volume":"33","author":"Pucci","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"2022010405125338800_b5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0161-6420(90)32477-6","article-title":"Atopic keratoconjunctiuvitis","volume":"97","author":"Foster","year":"1990","journal-title":"Ophthalmology"},{"key":"2022010405125338800_b6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archopht.1990.01070030090035","article-title":"Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"2022010405125338800_b7","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1067\/mai.2000.110930","article-title":"Tear and conjunctival changes during the allergen-induced early- and late-phase responses","volume":"106","author":"Bacon","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"2022010405125338800_b8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0091-6749(88)90020-6","article-title":"Inflammatory changes in conjunctival scrapings after allergen challenge in humans","volume":"82","author":"Bonini","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"2022010405125338800_b9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.preteyeres.2005.09.002","article-title":"Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis","volume":"25","author":"Kumagai","year":"2006","journal-title":"Prog Retina Eye Res"},{"key":"2022010405125338800_b10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2222.2006.02499.x","article-title":"Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures","volume":"36","author":"Leonardi","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"2022010405125338800_b11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1365-2222.1997.tb01258.x","article-title":"Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leukocyte infiltration","volume":"27","author":"Anderson","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"2022010405125338800_b12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0091-6749(05)80120-4","article-title":"Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis","volume":"86","author":"Irani","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"2022010405125338800_b13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/09273949609069126","article-title":"Human conjunctival mast cell responses in vitro to various secretagogues","volume":"4","author":"Miller","year":"1996","journal-title":"Ocular Immunol Inflamm"},{"key":"2022010405125338800_b14","first-page":"995","article-title":"The relative contribution of mast cell subsets to conjunctival T(H)2-like cytokines","volume":"42","author":"Anderson","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022010405125338800_b15","first-page":"336","article-title":"Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-alpha from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells","volume":"39","author":"Cook","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022010405125338800_b16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1034\/j.1600-0420.1999.770516.x","article-title":"Vernal keratoconjunctivitis in a Stockholm ophthalmic centre: epidemiological, functional, and immunologic investigations","volume":"77","author":"Montan","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"2022010405125338800_b17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0420.2005.00622.x","article-title":"Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study","volume":"84","author":"Leonardi","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"2022010405125338800_b18","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1046\/j.1365-2222.1999.00585.x","article-title":"Cytokine production and mRNA expression by conjunctival T cell lines in chronic allergic eye diseases","volume":"29","author":"Calder","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"2022010405125338800_b19","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00417-006-0285-7","article-title":"Th1- and Th2-type cytokines in chronic ocular allergy","volume":"244","author":"Leonardi","year":"2006","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"2022010405125338800_b20","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1167\/iovs.05-0138","article-title":"Role of Interferon-gamma in a mouse model of allergic conjunctivitis","volume":"46","author":"Stern","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022010405125338800_b21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.imlet.2006.08.003","article-title":"Analysis of the interaction between IFN\u03b3 and IFN\u03b3R in the effector phase of experimental murine allergic conjunctivitis","volume":"107","author":"Fukushima","year":"2006","journal-title":"Immunol Lett"},{"key":"2022010405125338800_b22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-6420(02)01767-0","article-title":"Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis","volume":"110","author":"Leonardi","year":"2003","journal-title":"Ophthalmology"},{"key":"2022010405125338800_b23","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bjo.85.11.1357","article-title":"Chemokine receptors in vernal keratoconjunctivitis","volume":"85","author":"El-Asrar","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"2022010405125338800_b24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2745.2003.01616.x","article-title":"Vernal keratoconjunctivitis: evidence for immunoglobulin E-dependent and immunoglobulin E-independent eosinophilia","volume":"33","author":"Ono","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"2022010405125338800_b25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.ico.0000114836.13127.45","article-title":"The relation of conjunctival and corneal findings in severe ocular allergies","volume":"23","author":"Tanaka","year":"2004","journal-title":"Cornea"},{"key":"2022010405125338800_b26","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1167\/iovs.02-0766","article-title":"Tear levels and activity of matrix metalloproteinases (MMP)-1 and MMP-9 in vernal keratoconjunctivitis","volume":"44","author":"Leonardi","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022010405125338800_b27","first-page":"4175","article-title":"Growth factors and collagen distribution in vernal keratoconjunctivitis","volume":"41","author":"Leonardi","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022010405125338800_b28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.exer.2004.11.006","article-title":"TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts","volume":"80","author":"Asano-Kato","year":"2005","journal-title":"Exp Eye Res"},{"key":"2022010405125338800_b29","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1167\/iovs.04-1196","article-title":"Urokinase plasminogen activator, uPA receptor and its inhibitor in veronal keratoconjunctivitis","volume":"46","author":"Leonardi","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022010405125338800_b30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1167\/iovs.06-0758","article-title":"Trypsin inhibitory capacity in vernal keratoconjunctivitis","volume":"48","author":"Gravami","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2022010405125338800_b31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archopht.124.4.462","article-title":"Altered expression of neurotrasmitter receptors and neuromediators in vernal keratoconjunctivitis","volume":"124","author":"Motterle","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"2022010405125338800_b32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/14728214.10.3.505","article-title":"Emerging drugs for ocular allergy","volume":"10","author":"Leonardi","year":"2005","journal-title":"Expert Opin Emerging Drugs"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03716.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2008.03716.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/153\/Supplement_1\/17\/42040635\/j.1365-2249.2008.03716.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/153\/Supplement_1\/17\/42040635\/j.1365-2249.2008.03716.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:14:32Z","timestamp":1641255272000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/153\/Supplement_1\/17\/6457446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,21]]},"references-count":32,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2008,7,21]]},"published-print":{"date-parts":[[2008,7,21]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03716.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,9]]},"published":{"date-parts":[[2008,7,21]]}}}